Ozempic ( semaglutide GLP-1 ) is a GLP-1 receptor agonist primarily prescribed for managing type 2 diabetes, though it is also effective for weight loss
Mounjaro puede contribuir a un mayor riesgo de tumores de clulas C de la tiroides, pancreatitis aguda, enfermedad de la vescula biliar, hipoglucemia, lesin renal aguda, efectos secundarios gastrointestinales graves, reacciones de hipersensibilidad y empeoramiento de la retinopata diabtica si padece diabetes tipo 2
Necessary cookies Always active These cookies are essential for the website to work properly and can't be switched off
Follow our simple three-step process to restore your energy, balance, and overall wellness
More efficient metabolism: may promote energy utilisation and support fat and protein metabolism